NCT04300036

Efficacy and Safety of Longan Syrup in Healthy Volunteers With Insomnia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Chulalongkorn University · Academic / Other
• Sex: All
• Age: 35 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The objectives of this study were to evaluate efficacy and safety of longan syrup in healthy volunteers with insomnia. Subjects will take 15 ml of longan syrup once a day for 3 months. They will be investigated their insomnia using Insomnia Severity Index (ISI) questionnaire, Thai- The Pittsburgh Sleep Quality Index (PSQI) questionnaire,STOP - BANG questionnaire, Epworth Sleepiness Scale (ESS) questionnaire, Actiwatch, plasma cortisol, aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), creatinine (Cr), blood urea nitrogen (BUN), fasting blood sugar, HbA1C, complete blood count (CBC), hemoglobin, lipid profile, phosphate level, saliva cortisol, and urine melatonin before and after taken longan syrup.

Conditions

• Insomnia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	longan syrup	Subjects will take 15 ml of longan syrup once a day for 3 months
DIETARY_SUPPLEMENT	Placebo syrup	Subjects will take 15 ml of placebo syrup once a day for 3 months

Timeline

• Start date: 2020-03-01
• Primary completion: 2021-01-30
• Completion: 2021-02-10
• First posted: 2020-03-09
• Last updated: 2020-03-10

Locations

1 site across 1 country: Thailand